Stock Events

Stock Events

Newron Pharmaceuticals Spa. 

$19.11
18
-$0.89-4.44% Thursday 12:05

Statistics

Day High
9.36
Day Low
9.36
52W High
20
52W Low
9.36
Volume
986
Avg. Volume
101
Mkt Cap
381.47M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

24MarExpected
Q4 2017
Q2 2022
Q4 2023
Q2 2024
Q1 2025
Q2 2025
Q4 2025
-1
-0.67
-0.33
0
Expected EPS
-0.518182536704
Actual EPS
-0.606088502752

Financials

30.46%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
106.51MRevenue
32.45MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NWPHF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Biogen Inc. focuses on discovering, developing, and delivering therapies for neurological and neurodegenerative diseases, directly competing with Newron's focus on central nervous system treatments.
Novartis
NVS
Mkt Cap237.61B
Novartis AG operates in the pharmaceuticals sector focusing on innovative medicines, including treatments for neurological conditions, making it a direct competitor.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including treatments for neurological disorders, competing in the same therapeutic areas as Newron.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. offers health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products, including efforts in neurology and neurodegenerative diseases.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company is engaged in the discovery, development, and marketing of pharmaceutical products, with a strong focus on neuroscience, making it a competitor.
Rogers
ROG
Mkt Cap1.57B
Roche Holding AG focuses on pharmaceuticals and diagnostics with a strong emphasis on neuroscience, including multiple sclerosis and spinal muscular atrophy treatments.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries Limited specializes in generic and specialty medicines, including CNS treatments, directly competing with Newron's product offerings.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. focuses on pharmaceuticals including neuroscience, where it is developing treatments for several neurological conditions, competing with Newron.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceutical, medical devices, and consumer health sectors, with its pharmaceutical segment developing treatments for neurological diseases.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including for neurological diseases, competing with Newron.

About

Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.
Show more...
CEO
Mr. Stefan Weber
Employees
22
Country
IT
ISIN
IT0004147952

Listings

XETRA
DE
NP5.XETRA
LSE
GB
0QOI.LSE
F
DE
NP5.F
SW
CH
NWRN.SW

0 Comments

Share your thoughts

FAQ

What is Newron Pharmaceuticals Spa. stock price today?▼
The current price of NWPHF is $19.11 USD — it has decreased by -4.44% in the past 24 hours. Watch Newron Pharmaceuticals Spa. stock price performance more closely on the chart.
What is Newron Pharmaceuticals Spa. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Newron Pharmaceuticals Spa. stocks are traded under the ticker NWPHF.
What is Newron Pharmaceuticals Spa. market cap?▼
Today Newron Pharmaceuticals Spa. has the market capitalization of 381.47M
When is the next Newron Pharmaceuticals Spa. earnings date?▼
Newron Pharmaceuticals Spa. is going to release the next earnings report on September 22, 2026.
What were Newron Pharmaceuticals Spa. earnings last quarter?▼
NWPHF earnings for the last quarter are -0.77 USD per share, whereas the estimation was -0.66 USD resulting in a -16.96% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Newron Pharmaceuticals Spa. revenue for the last year?▼
Newron Pharmaceuticals Spa. revenue for the last year amounts to 106.51M USD.
What is Newron Pharmaceuticals Spa. net income for the last year?▼
NWPHF net income for the last year is 32.45M USD.
How many employees does Newron Pharmaceuticals Spa. have?▼
As of April 05, 2026, the company has 22 employees.
In which sector is Newron Pharmaceuticals Spa. located?▼
Newron Pharmaceuticals Spa. operates in the Health Care sector.
When did Newron Pharmaceuticals Spa. complete a stock split?▼
Newron Pharmaceuticals Spa. has not had any recent stock splits.
Where is Newron Pharmaceuticals Spa. headquartered?▼
Newron Pharmaceuticals Spa. is headquartered in Bresso, IT.